Risultati di ricerca
5 giorni fa · G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses. Published: May 22, 2024. Jupiter Bioventures will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib for Radioprotection in the US ...
5 giorni fa · G1 Therapeutics. - Jupiter Bioventures will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib for Radioprotection in the US, Europe ...
4 giorni fa · G1 Therapeutics, Inc. ( GTHX ), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures, Wednesday announced a global licensing agreement for lerociclib for radioprotective uses. Jupiter Bioventures will get exclusive rights for the clinical development, regulatory submissions, and ...
5 giorni fa · A composite photo of Mars with its twin moons Phobos and Deimos. New research suggests the pair may in fact be two halves of an ancient comet captured by Mars long ago.
4 giorni fa · RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures, announced a global licensing agreement (excluding the Asia-Pacific region) for lerociclib for radioprotective ...
4 giorni fa · Deimos-2 is a Spanish Earth Observation Satellite as a follow-on to Deimos-1 that launched in 2009. The satellite was designed and developed by Satrec Initiative, an Elecnor company, for operator Deimos to acquire high-resolution images of Earth for a variety of purposes.
5 giorni fa · May 22, 2024. A biopharmaceutical company in Research Triangle Park has secured a stake in a new biotech through a recent licensing deal. G1 Therapeutics (Nasdaq: GTHX) on Wednesday announced a...
